STOCK TITAN

Histogen to Present at the 20th Annual Needham Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company, announced that CEO Richard W. Pascoe will present at the 20th Annual Needham Virtual Healthcare Conference. The presentation is scheduled for April 13, 2021, at 3:00 p.m. Eastern Time. A live webcast will be available, with a replay lasting 90 days on the company's Investors page. Histogen focuses on developing first-in-class restorative therapeutics aimed at enhancing the body's ability to repair itself, utilizing innovative technology involving cell-conditioned media and extracellular matrix materials.

Positive
  • None.
Negative
  • None.

SAN DIEGO, March 30, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Richard W. Pascoe, President and Chief Executive Officer of Histogen, will present at the 20th Annual Needham Virtual Healthcare Conference. The virtual presentation is scheduled for Tuesday, April 13, 2021 at 3:00 p.m. Eastern Time.

Presentation Details

Date: Tuesday April 13, 2021
Time: 3:00 p.m. Eastern Time (12:00 p.m. Pacific Time)
Live Webcast Link: https://wsw.com/webcast/needham107/hsto/2276780

For those not available to listen to the live broadcast, a replay will be archived for 90 days and available through the Investors page on www.histogen.com.

About Histogen
Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair. For more information, please visit www.histogen.com.

CONTACT:

Susan A. Knudson
Executive Vice President & CFO
Histogen Inc.
ir@histogen.com


FAQ

When is the Histogen (HSTO) presentation at the Needham Virtual Healthcare Conference?

The Histogen (HSTO) presentation is scheduled for April 13, 2021, at 3:00 p.m. Eastern Time.

Who is presenting for Histogen at the Needham Virtual Healthcare Conference?

Richard W. Pascoe, the President and CEO of Histogen, will present at the conference.

How can I access the Histogen (HSTO) presentation?

You can access the Histogen presentation through a live webcast link, which will be provided on their Investors page.

Is there a replay available for the Histogen (HSTO) conference presentation?

Yes, a replay of the Histogen (HSTO) conference presentation will be available for 90 days on their Investors page.

What is the focus of Histogen Inc. (HSTO)?

Histogen Inc. focuses on developing potential first-in-class restorative therapeutics to enhance the body's natural repair processes.

HISTOGEN INC

OTC:HSTO

HSTO Rankings

HSTO Latest News

HSTO Stock Data

939.79k
4.15M
2.85%
5.25%
1.57%
Biotechnology
Healthcare
Link
United States of America
San Diego